Ewenstein, B M <br/><br/>
Use of ristocetin cofactor activity in the management of von Willebrand disease.  [electronic resource] 

 -  Haemophilia : the official journal of the World Federation of Hemophilia  Jan 2001 
 - 10-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1351-8216 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2516.2001.00096.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biological Assay<br/>Drug Monitoring--methods<br/>Factor VIII--therapeutic use<br/>Humans<br/>Ristocetin<br/>von Willebrand Diseases--blood<br/>von Willebrand Factor--therapeutic use